J Antibiot (Tokyo). 1987 Sep;40(9):1249-55.

FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.

Kino T, Hatanaka H, Hashimoto M, Nishiyama M, Goto T, Okuhara M, Kohsaka M, Aoki H, Imanaka H.

Source

Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Ibaraki, Japan.

Abstract

FK-506, a novel immunosuppressant, has been isolated from the fermentation broth of Streptomyces tsukubaenis No. 9993 as colorless prism and the molecular formula was determined as C44H69NO12.H2O. The compound suppressed immune responses in vitro and in vivo with mice. This immunosuppressive effect was more potent than that of ciclosporin.

PMID:: 2445721; [PubMed - indexed for MEDLINE]

Free full text

LinkOut - more resources

Full Text Sources

J-STAGE, Japan Science and Technology Information Aggregator, Electronic

Molecular Biology Databases

PREDNISOLONE - HSDB

Supplemental Content

Save items

Related citations in PubMed

Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. [Transplant Proc. 1987]
Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis.
Goto T, Kino T, Hatanaka H, Nishiyama M, Okuhara M, Kohsaka M, Aoki H, Imanaka H. Transplant Proc. 1987 Oct; 19(5 Suppl 6):4-8.
FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. [J Antibiot (Tokyo). 1987]
FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.
Kino T, Hatanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T, Goto T, Okuhara M, Kohsaka M, Aoki H. J Antibiot (Tokyo). 1987 Sep; 40(9):1256-65.
FR-900520 and FR-900523, novel immunosuppressants isolated from a Streptomyces. II. Fermentation, isolation and physico-chemical and biological characteristics. [J Antibiot (Tokyo). 1988]
FR-900520 and FR-900523, novel immunosuppressants isolated from a Streptomyces. II. Fermentation, isolation and physico-chemical and biological characteristics.
Hatanaka H, Kino T, Miyata S, Inamura N, Kuroda A, Goto T, Tanaka H, Okuhara M. J Antibiot (Tokyo). 1988 Nov; 41(11):1592-601.
Review Suppressor factor activity in cell-mediated immune responses. [J Reticuloendothel Soc. 1978]
Review Suppressor factor activity in cell-mediated immune responses.
Rich SS, Rich RR, Kastner DL. J Reticuloendothel Soc. 1978 Oct; 24(4):417-25.
Review [Discovery and development of a novel immunosuppressant, tacrolimus hydrate]. [Yakugaku Zasshi. 1997]
Review [Discovery and development of a novel immunosuppressant, tacrolimus hydrate].
Tanaka H, Nakahara K, Hatanaka H, Inamura N, Kuroda A. Yakugaku Zasshi. 1997 Aug; 117(8):542-54.

See reviews... See all...

Cited by 75 PubMed Central articles

Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation. [Open Microbiol J. 2013]
Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation.
Kourtesi C, Ball AR, Huang YY, Jachak SM, Vera DM, Khondkar P, Gibbons S, Hamblin MR, Tegos GP. Open Microbiol J. 2013; 7:34-52. Epub 2013 Mar 22.
Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation. [Drug Des Devel Ther. 2013]
Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation.
Wu X, Hayes D Jr, Zwischenberger JB, Kuhn RJ, Mansour HM. Drug Des Devel Ther. 2013; 7:59-72. Epub 2013 Feb 4.
Therapeutic effect of 0.03% tacrolimus ointment for ocular graft versus host disease and vernal keratoconjunctivitis. [Korean J Ophthalmol. 2012]
Therapeutic effect of 0.03% tacrolimus ointment for ocular graft versus host disease and vernal keratoconjunctivitis.
Ryu EH, Kim JM, Laddha PM, Chung ES, Chung TY. Korean J Ophthalmol. 2012 Aug; 26(4):241-7. Epub 2012 Jul 24.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound
PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation,...
FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.
J Antibiot (Tokyo). 1987 Sep ;40(9):1249-55.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.

Source

Abstract

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 75 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information